Early research (Phase 1)Study completedNCT00003548What this trial is testingAminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityWho this might be right forCancer NYU Langone Health 20
Not applicableLooking for participantsNCT00900419What this trial is testingBiomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal VolunteersWho this might be right forEsophageal CancerHead and Neck CancerLung Cancer+1 more University of Colorado, Denver 700
Early research (Phase 1)Study completedNCT00397384What this trial is testingErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more National Cancer Institute (NCI) 43
Early research (Phase 1)WithdrawnNCT04602117What this trial is testingISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic CancerWho this might be right forHER2-positive Breast CancerHER2 LowSYD-985+24 more QuantumLeap Healthcare Collaborative
Testing effectiveness (Phase 2)Study completedNCT00019474What this trial is testingCombination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract CancerWho this might be right forExtrahepatic Bile Duct CancerGastric CancerGastrointestinal Carcinoid Tumor+3 more Montefiore Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT00004911What this trial is testingEndoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel ObstructionWho this might be right forColorectal CancerConstipation, Impaction, and Bowel ObstructionGastric Cancer+4 more Northwestern University
Very early researchActive Not RecruitingNCT04993261What this trial is testingAn Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid TumorsWho this might be right forCarcinoid SyndromeCarcinoid TumorDigestive System Neuroendocrine Tumor G1+1 more M.D. Anderson Cancer Center 71
Early research (Phase 1)Study completedNCT00006368What this trial is testingYttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerWho this might be right forBrain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Ended earlyNCT01886287What this trial is testingP:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid SyndromeWho this might be right forNeuroendocrine Carcinoma H. Lee Moffitt Cancer Center and Research Institute 2
Testing effectiveness (Phase 2)Study completedNCT01253161What this trial is testingStudy of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)Who this might be right forNeuroendocrine TumorsCarcinoid Tumors H. Lee Moffitt Cancer Center and Research Institute 29
Testing effectiveness (Phase 2)Study completedNCT00002470What this trial is testingFluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid TumorsWho this might be right forGastrointestinal Carcinoid TumorLung Cancer Mid-Atlantic Oncology Program
Testing effectiveness (Phase 2)Study completedNCT00004910What this trial is testingEndoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal ObstructionWho this might be right forColorectal CancerConstipation, Impaction, and Bowel ObstructionExtrahepatic Bile Duct Cancer+6 more Northwestern University
Not applicableUnknownNCT00454376What this trial is testingDisease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine TumorsWho this might be right forGastrointestinal Carcinoid TumorIslet Cell TumorLung Cancer+2 more National Cancer Institute (NCI) 408
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Post-approval studies (Phase 4)UnknownNCT00274885What this trial is testingRelationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal CancerWho this might be right forCancer GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Study completedNCT00454363What this trial is testingPazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine CancerWho this might be right forGastrin-Producing Neuroendocrine TumorLung Carcinoid TumorMetastatic Digestive System Neuroendocrine Tumor G1+8 more National Cancer Institute (NCI) 52
Early research (Phase 1)Study completedNCT00049023What this trial is testingRadiolabeled Octreotide in Treating Children With Advanced or Refractory Solid TumorsWho this might be right forBrain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more O'Dorisio, M S 27
Testing effectiveness (Phase 2)Study completedNCT00113360What this trial is testingRAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine CarcinomaWho this might be right forNeuroendocrine CarcinomaIslet Cell Carcinoma M.D. Anderson Cancer Center 67
Testing effectiveness (Phase 2)Study completedNCT00017199What this trial is testingPS-341 in Treating Patients With Metastatic Neuroendocrine TumorsWho this might be right forGastrointestinal Carcinoid TumorIslet Cell Tumor Ohio State University Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00084461What this trial is testingRomidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine TumorsWho this might be right forGastrinomaGlucagonomaInsulinoma+7 more National Cancer Institute (NCI) 25